106
Participants
Start Date
December 31, 2006
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
Docetaxel
Docetaxel at the dose of 30mg/m2 IV on days 1 and 8 every 3 weeks for 6 consecutive cycles
Gemcitabine
Gemcitabine at the dose of 900mg/m2 IV on days 1 and 8 every 3 weeks for 6 consecutive cycles
Gemcitabine
Gemcitabine at the dose of 1200mg/m2 IV on days 1 and 8 every 3 weeks for 6 consecutive cycles
University General Hospital of Alexandroupolis, Dep of Medical Oncology, Alexandroupoli
"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens
401 Military Hospital, Medical Oncology Unit, Athens
Air Forces Military Hospital, Dep of Medical Oncology, Athens
"IASO General Hospital of Athens, 1st Dep of Medical Oncology", Athens
Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases, Athens
"Sotiria General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases", Athens
"Metaxa's Anticancer Hospital of Piraeus,1st Dep of Medical Oncology", Piraeus
"Theagenion Anticancer Hospital of Thessaloniki", Thessaloniki
Lead Sponsor
University Hospital of Crete
OTHER
Hellenic Oncology Research Group
OTHER